| Joseph Palmisano, MD | |
|
263 Farmington Ave, Farmington, CT 06030-0001 | |
| (860) 679-2160 | |
| (860) 679-1042 |
| Full Name | Joseph Palmisano |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 263 Farmington Ave, Farmington, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487651816 | NPI | - | NPPES |
| 1239896 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 223989 (Connecticut) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | 023989 (Connecticut) | Primary |
| Entity Name | University Of Connecticut Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720083769 PECOS PAC ID: 3678472016 Enrollment ID: O20040106000105 |
News Archive
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.
New research from the Centers for Disease Control and Prevention estimates that as many as 200,000 central line-associated bloodstream infections have been prevented among patients in intensive care units since 1990.
The Fox Chase Cancer Center has received an $8 million grant from the National Center for Research Resources of the National Institutes of Health (NCRR/NIH) to expand their laboratory animal research facility. The new facility will support advanced research into the fundamental biological processes underlying cancer, opening the way for the development of new treatments. The funds for the grant were made available through the American Recovery and Reinvestment Act.
Researchers summarize what this rapid increase of plasticity of SARS-CoV-2 could mean for the future of the pandemic and anti-SARS-CoV-2 measures.
Brain inflammation caused by chronic nerve pain alters activity in regions that regulate mood and motivation, suggesting for the first time that a direct biophysical link exists between long-term pain and the depression, anxiety and substance abuse seen in more than half of these patients, UC Irvine and UCLA researchers report.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Palmisano, MD 263 Farmington Ave, Provider Enrollment, Farmington, CT 06030-2212 Ph: (860) 679-7503 | Joseph Palmisano, MD 263 Farmington Ave, Farmington, CT 06030-0001 Ph: (860) 679-2160 |
News Archive
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, today announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.
New research from the Centers for Disease Control and Prevention estimates that as many as 200,000 central line-associated bloodstream infections have been prevented among patients in intensive care units since 1990.
The Fox Chase Cancer Center has received an $8 million grant from the National Center for Research Resources of the National Institutes of Health (NCRR/NIH) to expand their laboratory animal research facility. The new facility will support advanced research into the fundamental biological processes underlying cancer, opening the way for the development of new treatments. The funds for the grant were made available through the American Recovery and Reinvestment Act.
Researchers summarize what this rapid increase of plasticity of SARS-CoV-2 could mean for the future of the pandemic and anti-SARS-CoV-2 measures.
Brain inflammation caused by chronic nerve pain alters activity in regions that regulate mood and motivation, suggesting for the first time that a direct biophysical link exists between long-term pain and the depression, anxiety and substance abuse seen in more than half of these patients, UC Irvine and UCLA researchers report.
› Verified 1 days ago
Maroun Sfeir, Nephrology Medicare: Not Enrolled in Medicare Practice Location: 263 Farmington Avenue, Farmington, CT 06030 Phone: 860-679-2980 Fax: 860-679-4334 | |
Andrew Arnold, MD Nephrology Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-3245 Fax: 860-679-1867 | |
Dr. Neelam Tailor, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Avenue, Farmington, CT 06030 Phone: 860-679-4763 Fax: 860-479-4624 | |
Dr. David K. Bowers, MD Nephrology Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06032 Phone: 860-679-4477 Fax: 860-679-1025 | |
Scott R Allen, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-4477 Fax: 860-679-1025 | |
Carl D Malchoff, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-3245 Fax: 860-679-1867 | |
Beatriz R Esayag-tendler, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-3343 Fax: 860-679-4256 |